Remote Assessment of Parkinson's Disease Patients Amidst the COVID-19 Lockdown in Mexico.

ABSTRACT: The COVID-19 pandemic introduced unprecedented challenges in managing patients with Parkinson's disease (PD) due to disruptions in healthcare services and the need for social distancing. Understanding the effects of COVID-19 on PD symptoms is crucial for optimizing patient care. We conducted a comprehensive analysis of the data obtained during the period of COVID-19 lockdown, comparing it with analogous timeframes in 2018 and 2019. Our objective was to examine the influence of this unique circumstance on both motor and non-motor symptoms in patients with PD. Telemedicine was employed to assess symptoms using the Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Our findings revealed a notable worsening of symptoms, evidenced by a significant increase

SUBMITTER: Leon-Garcia R 

PROVIDER: S-EPMC10377101 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature